Scintillation Proximity Assay as a High-Throughput Method to Identify Slowly Dissociating Nonpeptide Ligand Binding to the GnRH Receptor

¹ Neurocrine Biosciences, Inc., San Diego, CA.
² Synteract, Inc., Carlsbad, CA.

^* To whom correspondence should be addressed. E-mail: cheise{at}neurocrine.com.

	Abstract

Many nonpeptide antagonists of the gonadotropin-releasing hormone (GnRH) receptor, as well as other drug targets, possess a broad range of dissociation kinetic rate constants. Current methods to accurately define kinetic rate parameters such as K_on and K_off are time and labor intensive, prompting the development of a screening assay to identify slowly dissociating compounds for follow-up rate constant determination. The authors measured inhibition binding constants (K_i) for GnRH receptor antagonists after 30 min and 10 h of incubation and observed several compounds with markedly decreased K_i values over time (Ki_{30 min}/Ki_{10 h} > 6). They used scintillation proximity assay technology to perform these binding experiments because this homogeneous assay does not have a fixed termination end point as does filtration binding, permitting successive readings to be taken from the same assay plate over an extended period of time. They also used a quantitative method of kinetic rate analysis to confirm that a large disparity between a compound's K_i value at 30 min and 10 h could identify compounds that dissociate slowly. Thus, the K_i ratio can be used to screen for and select compounds to test using more quantitative, albeit lower throughput methods to accurately define kinetic rate constants.

Key Words: GPCR, kinetics, SPA, HTS, SAR

First published on January 4, 2007, doi:10.1177/1087057106297362

Journal of Biomolecular Screening 2007;12:235.

A more recent version of this article appeared on March 1, 2007


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?